23088-23-5 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 6-quinoxalinecarboxylate is used as a key intermediate in the synthesis of various pharmaceutical compounds due to its versatile reactivity and ability to form a wide range of organic compounds.
Used in Agrochemical Industry:
In the agrochemical sector, Methyl 6-quinoxalinecarboxylate serves as a building block for the development of new agrochemicals, contributing to the creation of innovative products for agricultural applications.
Used in Organic Synthesis:
Methyl 6-quinoxalinecarboxylate is employed as a valuable chemical in organic synthesis, enabling the formation of a diverse array of organic compounds for various applications.
Used in Antimicrobial Applications:
Leveraging its antimicrobial properties, Methyl 6-quinoxalinecarboxylate is utilized as an antimicrobial agent, helping to combat microbial infections and contributing to the development of new antimicrobial drugs.
Used in Antiparasitic Applications:
Capitalizing on its antiparasitic properties, Methyl 6-quinoxalinecarboxylate is applied in the development of antiparasitic drugs, targeting various parasitic infections and diseases.
Used in Anticancer Research:
Methyl 6-quinoxalinecarboxylate is used in pharmaceutical research for its potential anticancer properties, with ongoing studies exploring its efficacy in inhibiting cancer cell growth and its potential as a therapeutic agent in cancer treatment.
Check Digit Verification of cas no
The CAS Registry Mumber 23088-23-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,0,8 and 8 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 23088-23:
(7*2)+(6*3)+(5*0)+(4*8)+(3*8)+(2*2)+(1*3)=95
95 % 10 = 5
So 23088-23-5 is a valid CAS Registry Number.
InChI:InChI=1/C10H8N2O2/c1-14-10(13)7-2-3-8-9(6-7)12-5-4-11-8/h2-6H,1H3
23088-23-5Relevant academic research and scientific papers
Meta C-H Arylation of Electron-Rich Arenes: Reversing the Conventional Site Selectivity
Liu, Luo-Yan,Qiao, Jennifer X.,Yeung, Kap-Sun,Ewing, William R.,Yu, Jin-Quan
supporting information, p. 14870 - 14877 (2019/10/02)
Controlling site selectivity of C-H activation without using a directing group remains a significant challenge. While Pd(II) catalysts modulated by a mutually repulsive pyridine-type ligand have been shown to favor the relatively electron-rich carbon centers of arenes, reversing the selectivity to favor palladation at the relatively electron-deficient positions has not been possible. Herein we report the first catalytic system that effectively performs meta C-H arylation of a variety of alkoxy aromatics including 2,3-dihydrobenzofuran and chromane with exclusive meta site selectivity, thus reversing the conventional site selectivity governed by native electronic effects. The identification of an effective ligand and modified norbornene (NBE-CO2Me), as well as taking advantage of the statistics, are essential for achieving the exclusive meta selectivity.
Methyl 1,2,3,4-tetrahydroquinoxaline-6-carboxylate and preparation method thereof
-
, (2019/01/08)
The invention discloses methyl 1,2,3,4-tetrahydroquinoxaline-6-carboxylate and a preparation method thereof. The structure formula of methyl 1,2,3,4-tetrahydroquinoxaline-6-carboxylate is defined in the specification. The preparation method comprises the
INHIBITORS OF HISTONE DEACETYLASE
-
Page/Page column 222, (2010/02/11)
The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.
